AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1920342 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (50-100 mg once daily)
Number of subjects: 67
Study 1920342 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol (100-800 mg twice daily)
Number of subjects: 67
Study 1920342 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 67
Study 1920342 — intervention group
Group type: COMPARATOR
Intervention: Labetalol
Number of subjects: 67
Study 977134 — intervention group
Group type: EXPERIMENTAL
Intervention: Griseofulvin tablets containing dioctyl sodium sulfosuccinate, cetyl pyridinium chloride and polysorbate 80
Number of subjects: 128
Study 977134 — intervention group
Group type: COMPARATOR
Intervention: Griseofulvin tablets only
Number of subjects: 128
Study 31965616 — intervention group
Group type: EXPERIMENTAL
Intervention: Detomidine (0.03 mg/kg bwt)
Number of subjects: 57
Study 31965616 — intervention group
Group type: COMPARATOR
Intervention: Xylazine (1.1 mg/kg bwt)
Number of subjects: 57
Study 30642925 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir or efavirenz plus tenofovir disoproxil fumarate/emtricitabine
Number of subjects: 817
Study 30642925 — intervention group
Group type: COMPARATOR
Intervention: Atazanavir/ritonavir or efavirenz plus abacavir/lamivudine
Number of subjects: 817
Study 27732034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT) + Work Therapy
Number of subjects: 48
Study 27732034 — intervention group
Group type: COMPARATOR
Intervention: Work Therapy (Control)
Number of subjects: 48
Study 26684708 — intervention group
Group type: EXPERIMENTAL
Intervention: Green exercise intervention (outdoors in a green/nature area)
Number of subjects: 14
Study 26684708 — intervention group
Group type: COMPARATOR
Intervention: Indoor exercise setting (control group)
Number of subjects: 14
Study 23121002 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducative group therapy (six sessions during pregnancy and one after childbirth)
Number of subjects: 371
Study 23121002 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducative group therapy (n = 90 participants)
Number of subjects: 371
Study 23121002 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducative group therapy
Number of subjects: 371
Study 23121002 — intervention group
Group type: COMPARATOR
Intervention: Control group (care by community nurses and referral if necessary)
Number of subjects: 371
Study 21637086 — intervention group
Group type: EXPERIMENTAL
Intervention: GI‐NP (n = 50)
Number of subjects: 150
Study 21637086 — intervention group
Group type: COMPARATOR
Intervention: GI‐MD (n = 100)
Number of subjects: 150
Study 19386744 — intervention group
Group type: EXPERIMENTAL
Intervention: Phylloquinone (vitamin K1) supplementation (500 microg/d)
Number of subjects: 388
Study 19386744 — intervention group
Group type: COMPARATOR
Intervention: Multivitamin alone (control)
Number of subjects: 388
Study 16690701 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at approximately 67% VO2peak
Number of subjects: 18
Study 16690701 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 35%, 60%, and 85% VO2peak
Number of subjects: 18
Study 15503108 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP) 400 mg/d titrated to 1200 mg/d, then maintained or increased to 2400 mg/d or 3600 mg/d if not beneficial
Number of subjects: 26
Study 15503108 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 11687995 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic CPB (36 degrees C)
Number of subjects: 20
Study 11687995 — intervention group
Group type: COMPARATOR
Intervention: Hypothermic CPB (25 degrees C)
Number of subjects: 20
Study 9488070 — intervention group
Group type: EXPERIMENTAL
Intervention: HE-TUMT
Number of subjects: 52
Study 9488070 — intervention group
Group type: COMPARATOR
Intervention: TURP
Number of subjects: 52
Study 7996372 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroencephalographic abnormalities (burst suppression or electrographic seizure)
Number of subjects: 119
Study 7996372 — intervention group
Group type: EXPERIMENTAL
Intervention: Single recording of electrographic seizure or burst suppression
Number of subjects: 119
Study 7996372 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary resuscitation immediately before ECMO
Number of subjects: 119
Study 7996372 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest systolic blood pressure before or during ECMO
Number of subjects: 119
Study 2894070 — intervention group
Group type: EXPERIMENTAL
Intervention: Azo compounds (sulphasalazine and olsalazine)
Number of subjects: 8
Study 2894070 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release compounds (Pentasa, Asacol, and Salofalk)
Number of subjects: 8
Study 2894070 — intervention group
Group type: COMPARATOR
Intervention: Plain 5-ASA
Number of subjects: 8
Study 2894070 — intervention group
Group type: EXPERIMENTAL
Intervention: Azo compounds
Number of subjects: 8
Study 2894070 — intervention group
Group type: COMPARATOR
Intervention: Slow-release compounds
Number of subjects: 8
Study 29664951 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional follow-up (return only if illness continued)
Number of subjects: 4434
Study 29664951 — intervention group
Group type: COMPARATOR
Intervention: Universal follow-up (return regardless of illness resolution)
Number of subjects: 4434
Study 29664951 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional follow-up (caregiver-reported fever lasting ≥3 days)
Number of subjects: 4434
Study 29664951 — intervention group
Group type: COMPARATOR
Intervention: Universal follow-up (caregiver-reported fever lasting ≥3 days)
Number of subjects: 4434
Study 29664951 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional follow-up (axillary temperature measurement)
Number of subjects: 4434
Study 29664951 — intervention group
Group type: COMPARATOR
Intervention: Universal follow-up (axillary temperature measurement)
Number of subjects: 4434
Study 29664951 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional follow-up (post hoc analysis for malaria, diarrhea, pneumonia, danger signs, hospitalization, or death)
Number of subjects: 4434
Study 29664951 — intervention group
Group type: COMPARATOR
Intervention: Universal follow-up (post hoc analysis for malaria, diarrhea, pneumonia, danger signs, hospitalization, or death)
Number of subjects: 4434
Study 28648148 — intervention group
Group type: EXPERIMENTAL
Intervention: Debt advice provided by the CAB, treatment as usual (TAU), and two debt advice leaflets.
Number of subjects: 61
Study 28648148 — intervention group
Group type: COMPARATOR
Intervention: Advice leaflets provided by the general practitioner and TAU only.
Number of subjects: 61
Study 26286662 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A
Number of subjects: 35
Study 26286662 — intervention group
Group type: EXPERIMENTAL
Intervention: BITT
Number of subjects: 35
Study 26286662 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A + BITT
Number of subjects: 35
Study 26286662 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study 23302601 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG (with cardiopulmonary bypass)
Number of subjects: 40
Study 23302601 — intervention group
Group type: COMPARATOR
Intervention: OPCAB (without cardiopulmonary bypass)
Number of subjects: 40
Study 21961486 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized procaterol
Number of subjects: 140
Study 21961486 — intervention group
Group type: COMPARATOR
Intervention: Nebulized salbutamol
Number of subjects: 140
Study 18317194 — intervention group
Group type: EXPERIMENTAL
Intervention: ProDisc-L lumbar disc replacement
Number of subjects: 42
Study 16981402 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure assessment based on a single job for active workers and longest job for retired or deceased workers; assessed using a job-exposure matrix.
Number of subjects: 147062
Study 16981402 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to hazardous factors such as dust, silica, PAHs, CO, and heat.
Number of subjects: 147062
Study 12706031 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy intervention program
Number of subjects: 40
Study 12706031 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 40
Study 11576573 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 140
Study 11576573 — intervention group
Group type: COMPARATOR
Intervention: Plain saline
Number of subjects: 140
Study 15321209 — intervention group
Group type: EXPERIMENTAL
Intervention: Early administration of epidural bupivacaine (0.25%) at cervical dilatation <4 cm
Number of subjects: 60
Study 15321209 — intervention group
Group type: COMPARATOR
Intervention: Late administration of epidural bupivacaine (0.25%) at cervical dilatation >=4 cm
Number of subjects: 60
Study 8151722 — intervention group
Group type: EXPERIMENTAL
Intervention: Survanta
Number of subjects: 41
Study 8151722 — intervention group
Group type: COMPARATOR
Intervention: Exosurf
Number of subjects: 41
Study 8151722 — intervention group
Group type: COMPARATOR
Intervention: Survanta vs Exosurf
Number of subjects: 41
Study 2904373 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam (0.5 micrograms kg‐1 min‐1)
Number of subjects: 8
Study 2904373 — intervention group
Group type: COMPARATOR
Intervention: Control saline infusion
Number of subjects: 8
Study 2904373 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 8
Study 2904373 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II
Number of subjects: 8
Study 31805247 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonomotor treatment (56-60 hr over 6 weeks)
Number of subjects: 58
Study 31805247 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantic Feature Analysis (SFA) treatment (56-60 hr over 6 weeks)
Number of subjects: 58
Study 27836235 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop insulin delivery (using a model-predictive control algorithm to direct subcutaneous delivery of rapid-acting insulin analogue without meal-time insulin boluses)
Number of subjects: 40
Study 27836235 — intervention group
Group type: COMPARATOR
Intervention: Conventional subcutaneous insulin delivery according to local clinical guidelines
Number of subjects: 40
Study 26159017 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with physical training and relearning
Number of subjects: 364
Study 26159017 — intervention group
Group type: COMPARATOR
Intervention: Physical training and relearning (Control)
Number of subjects: 364
Study 24953206 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple boceprevir-based antiviral therapy
Number of subjects: 35
Study 22103798 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous coronary artery bypass grafting and carotid endarterectomy
Number of subjects: 1160
Study 22103798 — intervention group
Group type: COMPARATOR
Intervention: Isolated coronary artery bypass grafting
Number of subjects: 1160
Study 19277904 — intervention group
Group type: EXPERIMENTAL
Intervention: IA TPA (22 mg over 2 h)
Number of subjects: 7
Study 19277904 — intervention group
Group type: COMPARATOR
Intervention: IV TPA (per NINDS protocol)
Number of subjects: 7
Study 19277904 — intervention group
Group type: EXPERIMENTAL
Intervention: IA TPA
Number of subjects: 7
Study 19277904 — intervention group
Group type: COMPARATOR
Intervention: IV TPA
Number of subjects: 7
Study 17318803 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial nail avulsion with phenol
Number of subjects: 123
Study 17318803 — intervention group
Group type: COMPARATOR
Intervention: Partial nail avulsion with matrix excision
Number of subjects: 123
Study 17318803 — intervention group
Group type: EXPERIMENTAL
Intervention: Local application of gentamicin (antibiotic)
Number of subjects: 123
Study 15545368 — intervention group
Group type: EXPERIMENTAL
Intervention: IgY‐urease yogurt (test group)
Number of subjects: 42
Study 15545368 — intervention group
Group type: COMPARATOR
Intervention: IgY‐urease-free yogurt (control group)
Number of subjects: 42
Study 11443568 — intervention group
Group type: EXPERIMENTAL
Intervention: Meningococcal C conjugate (MCC) vaccine after MACP vaccination
Number of subjects: 0
Study 11443568 — intervention group
Group type: COMPARATOR
Intervention: Meningococcal C conjugate (MCC) vaccine
Number of subjects: 0
Study 11443568 — intervention group
Group type: EXPERIMENTAL
Intervention: Meningococcal AC polysaccharide (MACP) vaccination
Number of subjects: 0
Study 11443568 — intervention group
Group type: EXPERIMENTAL
Intervention: Meningococcal C conjugate (MCC) vaccination
Number of subjects: 0
Study 9860404 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1.4 mg/kg BW, n = 10 patients)
Number of subjects: 20
Study 9860404 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9% solution (n = 10 patients)
Number of subjects: 20
Study 8700604 — intervention group
Group type: EXPERIMENTAL
Intervention: Lullabies
Number of subjects: 20
Study 8700604 — intervention group
Group type: COMPARATOR
Intervention: Mother's voice
Number of subjects: 20
Study 2707048 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (2 g intravenously pre‐operatively)
Number of subjects: 200
Study 2707048 — intervention group
Group type: COMPARATOR
Intervention: Clavulanate-potentiated amoxycillin (1200 mg, repeated for 2 more doses if necessary)
Number of subjects: 200
Study 883332 — intervention group
Group type: EXPERIMENTAL
Intervention: Total mastectomy
Number of subjects: 1700
Study 883332 — intervention group
Group type: EXPERIMENTAL
Intervention: Total mastectomy with postoperative regional radiotherapy
Number of subjects: 1700
Study 883332 — intervention group
Group type: COMPARATOR
Intervention: Total mastectomy without postoperative regional radiotherapy (with axillary dissection if clinically positive nodes developed)
Number of subjects: 1700
Study 883332 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental mastectomy plus axillary dissection
Number of subjects: 1700
Study 883332 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental mastectomy plus axillary dissection plus postoperative radiation
Number of subjects: 1700
Study 883332 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy for patients with histologically positive axillary nodes
Number of subjects: 1700
Study 31948365 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroop task
Number of subjects: 210
Study 31948365 — intervention group
Group type: EXPERIMENTAL
Intervention: Binary classification task
Number of subjects: 210
Study 31948365 — intervention group
Group type: EXPERIMENTAL
Intervention: Markus and Peters arithmetic test
Number of subjects: 210
Study 31948365 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 210
Study 31948365 — intervention group
Group type: COMPARATOR
Intervention: Imagined fatigue
Number of subjects: 210
Study 31521777 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive modules on clinical assessment, care planning, and technological dependency
Number of subjects: 94
Study 31521777 — intervention group
Group type: COMPARATOR
Intervention: Noncomplex care topics (Control)
Number of subjects: 94
Study 31625947 — intervention group
Group type: EXPERIMENTAL
Intervention: My Tools 4 Care (MT4C) intervention, accessed for three months.
Number of subjects: 92
Study 28900452 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum home care service
Number of subjects: 276
Study 28900452 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 276
Study 25841289 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-clean technique
Number of subjects: 40
Study 25841289 — intervention group
Group type: COMPARATOR
Intervention: Ideal technique
Number of subjects: 40
Study 23652330 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone combined with systemic prednisolone
Number of subjects: 92
Study 23652330 — intervention group
Group type: COMPARATOR
Intervention: Systemic prednisolone alone
Number of subjects: 92
Study 23652330 — intervention group
Group type: EXPERIMENTAL
Intervention: Post hoc analysis excluding individuals with profound hearing loss
Number of subjects: 92
Study 21385249 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (one-hour single music session)
Number of subjects: 98
Study 21385249 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal relaxation (30 minutes of guided relaxation)
Number of subjects: 98
Study 21385249 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 98
Study 19302392 — intervention group
Group type: EXPERIMENTAL
Intervention: modSLA surface
Number of subjects: 40
Study 19302392 — intervention group
Group type: COMPARATOR
Intervention: SLA surface
Number of subjects: 40
Study 19023677 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 IV over 10 min and gemcitabine 800 mg/m2 IV at 10 mg/m2 per minute on days 1 and 15 of an every-4-weeks schedule with vitamin B12 and folate supplementation
Number of subjects: 63
Study 19023677 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 63
Study 15017629 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy with a proton pump inhibitor (PPI), amoxicillin, and clarithromycin; Omeprazole 20 mg or Lansoprazole 30 mg twice daily; Clarithromycin 200 mg 3 times daily; Amoxicillin 500 mg 3 times daily for 1 week
Number of subjects: 336
Study 11520590 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride containing dentifrice (1500 ppm)
Number of subjects: 22
Study 11520590 — intervention group
Group type: COMPARATOR
Intervention: Fluoride free dentifrice
Number of subjects: 22
Study 9568665 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic transabdominal preperitoneal repair
Number of subjects: 240
Study 9568665 — intervention group
Group type: EXPERIMENTAL
Intervention: Open plug and patch repair
Number of subjects: 240
Study 9568665 — intervention group
Group type: EXPERIMENTAL
Intervention: Shouldice's operation
Number of subjects: 240
Study 9347286 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (25 E% protein)
Number of subjects: 65
Study 9347286 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-protein diet (12 E% protein)
Number of subjects: 65
Study 9347286 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet (controls)
Number of subjects: 65
Study 1774727 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled infuser system (2.0 mg incremental dose with a 10-minute lock-out interval)
Number of subjects: 47
Study 1774727 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular (IM) injections (10-15 mg every three hours)
Number of subjects: 47
Study 6167759 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleomycin in addition to conventional four drug regimen (vincristine, adriamycin, cyclophosphamide, actinomycin D)
Number of subjects: 100
Study 6167759 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy for local control (4600 rad or 6000 rad)
Number of subjects: 100
Study 30944103 — intervention group
Group type: EXPERIMENTAL
Intervention: rhNGF eye drops at 20 μg/mL (Group 1: G1)
Number of subjects: 40
Study 30944103 — intervention group
Group type: EXPERIMENTAL
Intervention: rhNGF eye drops at 4 μg/mL (Group 2: G2)
Number of subjects: 40
Study 31285214 — intervention group
Group type: EXPERIMENTAL
Intervention: Appointments scheduled with advanced practitioners
Number of subjects: 3742
Study 26030354 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vaccination with live attenuated E. ictaluri isolate (1:100 dilution, ∼5 × 10⁶ CFU/g of feed)
Number of subjects: 0
Study 26030354 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vaccination with live attenuated E. ictaluri isolate (1:10 dilution, ∼5 × 10⁷ CFU/g of feed)
Number of subjects: 0
Study 26030354 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vaccination
Number of subjects: 0
Study 26030354 — intervention group
Group type: COMPARATOR
Intervention: Nonvaccinated controls
Number of subjects: 0
Study 24687088 — intervention group
Group type: EXPERIMENTAL
Intervention: CPX-351
Number of subjects: 126
Study 22562734 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) training combined with endurance training
Number of subjects: 14
Study 22562734 — intervention group
Group type: COMPARATOR
Intervention: Endurance training without WBV
Number of subjects: 14
Study 22562734 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (WBV and no-WBV)
Number of subjects: 14
Study 21314226 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/DM Smart Form
Number of subjects: 10
Study 21314226 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 10
Study 21314226 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/DM Smart Form (on-treatment analysis)
Number of subjects: 10
Study 21314226 — intervention group
Group type: COMPARATOR
Intervention: Usual care (on-treatment analysis)
Number of subjects: 10
Study 18366374 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic play intervention
Number of subjects: 203
Study 15973964 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (25 mg twice daily)
Number of subjects: 20
Study 15973964 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (25 mg twice daily) after exercise
Number of subjects: 20
Study 15973964 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 20
Study 15973964 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 12811776 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (14 weeks, 3 times per week, 2 series of 10 repetitions at 80% of 5-repetition maximum)
Number of subjects: 7
Study 12811776 — intervention group
Group type: COMPARATOR
Intervention: Control group (age 66.4 ± 1.7 years; n = 7)
Number of subjects: 7
Study 10488675 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic stimulation of the motor cortex
Number of subjects: 32
Study 8961776 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose gepirone-ER (20-100 mg)
Number of subjects: 145
Study 8961776 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose gepirone-ER (10-50 mg)
Number of subjects: 145
Study 8961776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 1383622 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine 240 mg
Number of subjects: 104
Study 1383622 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine plasma levels above 500 ng/ml
Number of subjects: 104
Study 1383622 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine plasma levels below 500 ng/ml
Number of subjects: 104
Study 2866135 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg once daily
Number of subjects: 71